Acura Pharmaceuticals (OTC: ACUR)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Acura Pharmaceuticals Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acura Pharmaceuticals Company Info
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
News & Analysis
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."
These stocks bounced higher yesterday, but are they about to make a return trip to Earth?
A weekly adventure in giving unknown companies some attention.
Are these three stocks about to make a large move?
A look at the biggest stories this week in biotech and what they mean for investors.
Market-lagging returns could be written in this 1-Star.
Another abuse-resistant drug for Acura sees a huge jump in share price.
None
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.